12:00 AM
 | 
Apr 24, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

CpG 7909: Began Phase I/II trial

Coley Pharmaceutical Group Inc., Wellesley, Mass.
Product: CpG 7909
Business: Cancer
Therapeutic category: Adjuvant, Immune stimulation...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >